Buccal Misoprostol During Cesarean Section for Preventing Postpartum Hemorrhage in Women With Risk Factors for Uterine Atony
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Misoprostol (Primary)
- Indications Postpartum haemorrhage; Uterine inertia
- Focus Therapeutic Use
- 11 Oct 2018 Biomarkers information updated
- 04 Jan 2013 New trial record